[639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME
Nicola Coppola(University of Campania "Luigi Vanvitelli"), Evangelista Sagnelli(University of Campania "Luigi Vanvitelli"), Pietro Filippini(University of Campania "Luigi Vanvitelli"), F Piccinino(University of Campania "Luigi Vanvitelli"), Gilda Tonziello(Ospedale Sant'Anna), Maria Stanzione(University of Campania "Luigi Vanvitelli"), Salvatore Martini(University of Campania "Luigi Vanvitelli"), Raffaella Pisapia(University of Naples Federico II), Michele Imparato(University of Campania "Luigi Vanvitelli"), Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), G. Piai(Ospedale Sant'Anna)
Cited by 1
Related Papers
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
|Journal of Hepatology|2023|94
Clinical significance of hepatitis B surface antigen mutants
|World Journal of Hepatology|2015|87